Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients

Journal of Proteome Research

Volumn 8, Issue 1, 2009, Pages 335-345

  Von Muhlen, Constantin Zur ^a   Schiffer, Eric ^b   Zuerblg, Petra ^b   Kellmann, Marcus ^c   Brasse, Mario ^a   Meert, Natalie ^d   Vanholder, Raymond C ^d   Dominiczak, Anna F ^e   Chen, Yung Chin ^f   Mischak, Harald ^b   Bode, Christoph ^a   Peter, Karlheinz ^f  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^c Thermo Electron   (Germany)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Coronary artery disease; Peptide pattern; Proteome; Urine

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; POLYPEPTIDE; PROTEOME; COLLAGEN; PEPTIDE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEOMICS; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SINGLE BLIND PROCEDURE; URINALYSIS; ATHEROSCLEROSIS; CHEMISTRY; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; METABOLISM; METHODOLOGY; TEMPERATURE; URINE;

ANGINA;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; COLLAGEN; CORONARY ARTERY DISEASE; ELECTROPHORESIS, CAPILLARY; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEOME; PROTEOMICS; TEMPERATURE; URINE;

EID: 60849126133     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800615t     Document Type: Article

References (42)

1. Corti, R.; Farkouh, M. E.; Badimon, J. J. The vulnerable plaque and acute coronary syndromes. Am. J. Med. 2002, 113 (8), 668-80.
2. Grodos, D.; Tonglet, R. Scandinavian simvastatin study (4S). Lancet 1994, 344 (8939-8940), 1768.
3. Arroyo-Espliguero, R.; Avanzas, P.; Cosin-Sales, J.; Aldama, G.; Pizzi, C.; Kaski, J. C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur. Heart J. 2004, 25 (5), 401-8.
4. Kaiser, T.; Wittke, S.; Just, I.; Krebs, R.; Bartel, S.; Fliser, D.; Mischak, H.; Weissinger, E. M. Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophoresis 2004,25 (13), 2044-55.
5. Wittke, S.; Fliser, D.; Haubitz, M.; Bartel, S.; Krebs, R.; Hausadel, F.; Hillmann, M.; Golovko, I.; Koester, P.; Haller, H.; Kaiser, T.; Mischak, H.; Weissinger, E. M. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J. Chromatogr., A 2003, 1013 (1-2), 173-81.
6. Issaq, H. J.; Chan, K. C.; Janini, G. M.; Conrads, T. P.; Veenstra, T. D. Multidimensional separation of peptides for effective pro-teomic analysis. J. Chromatogr., B: Anal. Technol Biomed. Life Sci. 2005, 877(1), 35-47.
7. Theodorescu, D.; Wittke, S.; Ross, M. M.; Walden, M.; Conaway, M.; Just, I.; Mischak, H.; Frierson, H. F. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 2006, 7 (3), 230-10.
8. Schaub, S.; Wilkins, J.; Weiler, T.; Sangster, K.; Rush, D.; Nickerson, P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 2004, 65 (1), 323-32.
9. Zimmerli, L. U.; Schiffer, E.; Zurbig, P.; Good, D. M; Kellmann, M.; Mouls, L.; Pitt, A. R.; Coon, J. J.; Schmieder, R. E.; Peter, K. H.; Mischak, H.; Kolch, W.; Delles, C.; Dominiczak, A. F. Urinary proteomic biomarkers in coronary artery disease. Mol. Cell. Proteomics 2008, 7 (2), 290-8.
10. Mischak, H.; Apweiler, R.; Banks, R. E.; Conaway, M.; Coon, J. J.; Dominizak, A.; Ehrich, J. H.; Fliser, D.; Girolami, M.; Hermjakob, H.; Hochstrasser, D. F.; Jankowski, V.; Julian, B. A.; Kolch, W.; Massy, Z.; Neususs, C.; Novak, J.; Peter, K.; Rossing, K.; Schanstra, J. P.; Semmes, O. J.; Theodorescu, D.; Thongboonkerd, V.; Weissinger, E. M.; Van Eyk, J. E.; Yamamoto, T. Clinical Proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
11. Taylor, C. F.; Paton, N. W.; Lilley, K. S.; Binz, P. A.; Julian, R. K., Jr.; Jones, A. R.; Zhu, W.; Apweiler, R.; Aebersold, R.; Deutsch, E. W.; Dunn, M. J.; Heck, A. J.; Leitner, A.; Macht, M.; Mann, M.; Martens, L.; Neubert, T. A.; Patterson, S. D.; Ping, P.; Seymour, S. L.; Souda, P.; Tsugita, A.; Vandekerckhove, J.; Vondriska, T. M.; Whitelegge, J. P.; Wilkins, M. R.; Xenarios, I.; Yates, J. R., 3rd; Hermjakob, H. The minimum information about a proteomics experiment (MI-APE). Nat. Biotechnol. 2007, 25 (8), 887-93.
12. Cham, B. E.; Knowles, B. R. A solvent system for delipidation of plasma or serum without protein precipitation. J. Lipid Res. 1976, 17(2), 176-81.
13. Kolch, W.; Neususs, C.; Pelzing, M.; Mischak, H. Capillary elec-trophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 2005, 24 (6), 959-77.
14. DeLeo, J. Receiver operating characteristics laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty. Proceedings of the Second International Symposium on Uncertainty Modeling and Analysis, University of Maryland College Park, MD, April 25-28, 1993.
15. Zurbig, P.; Renfrow, M. B.; Schiffer, E.; Novak, J.; Walden, M.; Wittke, S.; Just, I.; Pelzing, M.; Neususs, G; Theodorescu, D.; Root, K. E.; Ross, M. M.; Mischak, H. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 2006, 27 (11), 2111-25.
16. Theodorescu, D.; Mischak, H. Mass spectrometry based proteomics in urine biomarker discovery. World J. Urol. 2007, 25 (5), 435-43.
17. Mueller, J.; von Eggeling, F.; Driesch, D.; Schubert, J.; Melle, C.; Junker, K. ProteinChip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients. Eur. Urol. 2005, 47 (6), 885-93, discussion 893-4.
18. Weissinger, E. M.; Nguyen-Khoa, T.; Fumeron, C.; Saltiel, C.; Walden, M.; Kaiser, T.; Mischak, H.; Drueke, T. B.; Lacour, B.; Massy, Z. A. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics 2006, 6 (3), 993-1000.
19. Theodorescu, D.; Fliser, D.; Wittke, S.; Mischak, H.; Krebs, R.; Walden, M.; Ross, M.; Eltze, E.; Bettendorf, O.; Wulfing, C.; Semjonow, A. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 2005, 26 (14), 2797-808.
20. Mischak, H.; Kaiser, T.; Walden, M.; Hillmann, M.; Wittke, S.; Herrmann, A.; Knueppel, S.; Haller, H.; Fliser, D. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin. Sci. 2004, 107 (5), 485-95.
21. Chalmers, M. J.; Kolch, W.; Emmett, M. R.; Marshall, A. G.; Mischak, H. Identification and analysis of phosphopeptides. J. Chromatogr., B-.Anal. Technol. Biomed. Life Sci. 2004, 803 (1), 111-20.
22. Decramer, S.; Wittke, S.; Mischak, H.; Zurbig, P.; Walden, M.; Bouissou, F.; Bascands, J. L.; Schanstra, J. P. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 2006, 12 (4), 398-400.
23. Maisel, A. S.; Bhalla, V.; Braunwald, E. Cardiac biomarkers: a contemporary status report. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3 (1), 24-34.
24. Weissinger, E. M.; Wittke, S.; Kaiser, T.; Haller, H.; Bartel, S.; Krebs, R.; Golovko, I.; Rupprecht, H. D.; Haubitz, M.; Hecker, H.; Mischak, H.; Fliser, D. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004, 65 (6), 2426-34.
25. Ganesh, S. K.; Sharma, Y.; Dayhoff, J.; Fales, H. M.; Van Eyk, J.; Kickler, T. S.; Billings, E. M.; Nabel, E. G. Detection of venous thromboembolism by proteomic serum biomarkers. PLoS ONE 2007, 2, e544.
26. Schiffrin, E. L.; Lipman, M. L.; Mann, J. F. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007,116 (1), 85-97.
27. Kundhal, K.; Lok, C. E. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin. Pract. 2005, 101 (2), c47-52.
28. Best, P. J.; Reddan, D. N.; Berger, P. B.; Szczech, L. A.; McCullough, P. A.; Califf, R. M. Cardiovascular disease and chronic kidney disease: insights and an update. Am. Heart J. 2004, 148 (2), 230-42.
29. Duran, M. C.; Mas, S.; Martin-Ventura, J. L.; Meilhac, O.; Michel, J. B.; Gallego-Delgado, J.; Lazaro, A.; Tunon, J.; Egido, J.; Vivanco, F. Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 2003, 3 (6), 973-8.
30. Mayr, M.; Chung, Y. L.; Mayr, U.; Yin, X.; Ly, L.; Troy, H.; Fredericks, S.; Hu, Y.; Griffiths, J. R.; Xu, Q. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler., Thromb., Vase. Biol. 2005,25 (10), 2135-42.
31. Good, D. M.; Wirtala, M.; McAlister, G. C.; Coon, J. J. Performance characteristics of electron transfer dissociation mass spectrometry. Mol. Cell. Proteomics 2007, 6 (11), 1942-51.
32. Good, D. M.; Coon, J. J. Advancing proteomics with ion/ion chemistry. BioTechniques 2006, 40 (6), 783-9.
33. Gebauer, P.; Beckers, J. L.; Bocek, P. Theory of system zones in capillary zone electrophoresis. Electrophoresis 2002, 23 (12), 1779-85.
34. Li, J.; Wang, C.; Kelly, J. F.; Harrison, D. J.; Thibault, P. Rapid and sensitive separation of trace level protein digests using microfab-ricated devices coupled to a quadrupole-time-of-flight mass spectrometer. Electrophoresis 2000, 21 (1), 198-210.
35. Li, J.; LeRiche, T.; Tremblay, T. L.; Wang, C.; Bonneil, E.; Harrison, D. J.; Thibault, P. Application of microfluidic devices to proteomics research: identification of trace-level protein digests and affinity capture of target peptides. Mol. Cell. Proteomics 2002, 1 (2), 157-68.
36. Shekhonin, B. V.; Domogatsky, S. P.; Idelson, G. L.; Koteliansky, V. E.; Rukosuev, V. S. Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. Atherosclerosis 1987, 67 (1), 9-16.
37. Shekhonin, B. V.; Domogatsky, S. P.; Muzykantov, V. R.; Idelson, G. L.; Rukosuev, V. S. Distribution of type I, II, IV and V collagen in normal and atherosclerotic human arterial wall: immunomor-phological characteristics. Collagen Relat. Res. 1985, 5 (4), 355-68.
38. Penz, S.; Reininger, A. J.; Brandl, R.; Goyal, P.; Rabie, T.; Bern-lochner, I.; Rother, E.; Goetz, C.; Engelmann, B.; Smethurst, P. A.; Ouwehand, W. H.; Farndale, R.; Nieswandt, B.; Siess, W. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J. 2005, 19 (8), 898-909.
39. Megens, R. T.; Oude Egbrink, M. G.; Cleutjens, J. P.; Kuijpers, M. J.; Schiffers, P. H.; Merkx, M.; Slaaf, D. W.; van Zandvoort, M. A. Imaging collagen in intact viable healthy and atherosclerotic arteries using fluorescently labeled CNA35 and two-photon laser scanning microscopy. Mol. Imaging 2007, 6 (4), 247-60.
40. Noji, Y.; Kajinami, K.; Kawashiri, M. A.; Todo, Y.; Horita, T.; Nohara, A.; Higashikata, T.; Inazu, A.; Koizumi, J.; Takegoshi, T.; Mabuchi, H. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin. Chem. Lab. Med. 2001, 39 (5), 380-4.
41. Zouridakis, E.; Avanzas, P.; Arroyo-Espliguero, R.; Fredericks, S.; Kaski, J. C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004, 110 (13), 1747-53.
42. Deguchi, J. O.; Aikawa, M.; Tung, C. H.; Aikawa, E.; Kim, D. E.; Ntziachristos, V.; Weissleder, R.; Libby, P. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006, 114 (1), 55-62.